ClinicalTrials.Veeva

Menu

Multidisciplinary Care After Prostatectomy (MCAP)

P

Provence Private hospital

Status

Not yet enrolling

Conditions

Prostate Cancer

Treatments

Other: Multidisciplinary program

Study type

Interventional

Funder types

Other

Identifiers

NCT05644197
2021-A03118-33

Details and patient eligibility

About

This is a pilot, prostective, comparative, randomized, monocentric open-label study whose main objective is to determine whether appropriate psychological, nutritional and physical activity support can improve the quality of life of carrier patients. localized prostate cancer treated by prostatectomy

Full description

Pilot study to demonstrate the benefits of a multimodal intervention (psychological and nutritional support and physical activity) on the recovery of patients treated by prostatectomy for localized prostate cancer.

After inclusion of 100 patients, at week 6 will undergo a prostatectomy and then at week 9 will be randomized into two groups of 50 patients for each group.

Groupe Intervention which will benefit from multidisciplinary care over 12 weeks (one APA session per week plus 5 workshops with the psychologist and a workshop with the dietician) plus a visit with the urologist.

Then after 3 months, 6 months and 12 months, the group benefit from an evaluation with the urologist, the teacher of adapted physical activity and the dietitian.

-For the control group, it will be followed classically, a visit to the urologist, an assessment with the teacher of physical activity and the dietician, after prostatectomy, then at 3 months, 6 months and at 12 months.

Enrollment

100 estimated patients

Sex

Male

Ages

18 to 72 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

WHO score 0 or 1

  • Adult patients with localized prostate cancer eligible for surgical treatment according to the AFU criteria following the CAPRA and d'Amico classifications: low risk or risk intermediaries. These are patients under the age of 73, with clinical stage and or MRI < or = T3, PSA < or = 20 ng/ml, with assessment negative extension (bone scintigraphy, thoraco-abdomino-pelvic scanner, Choline Pet-scanner)
  • Informed and written consent signed by the patient
  • Person affiliated with social security or beneficiary of such a scheme

Exclusion criteria

WHO score greater than or equal to 2

  • MMSE score below 20
  • Persons referred to in Articles L1121-5 to L1121-8 of the CSP (corresponds to all protected persons: person deprived of liberty by judicial or administrative decision, person subject to a legal protective measure)

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

100 participants in 2 patient groups

intervention group
Other group
Description:
the intervention group of 50 patients will undergo a support program over 12 weeks (1 adapted physical activity session per week, will participate in 5 workshops with the psychologist and 1 workshop with the dietician, plus a visit with the urologist after 6 weeks from prostatectomy
Treatment:
Other: Multidisciplinary program
control group
No Intervention group
Description:
the control group will only undergo a classic follow-up during its 12 weeks, namely a visit to the urologist after 6 weeks of the prostatectomy

Trial contacts and locations

0

Loading...

Central trial contact

David BARRIOL, Urologist; Salima DELLYS, CRA

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems